3. Gains (losses) on disposals and impairments of investments, net

Details are as follows:

    9 months to September 30
Quarter III
€ million 2013   2012   Change 2013 2012 Change
Disposals:                
SGS 1,534.0 (a) 0,0   1,534.0 0.0 0.0 0.0
Alpitour (3.0) (b) 162.3 (c) (165.3) (0.5) (0.6) 0.1
Other
(0.5)   5.1   (5.6) (1.0) (0.1) (0.9)
Sequana, diluition on share icrease
0,0   (147.4) (d) 147.4 0.0 0.0 0.0
Total 1,530.5   20.0   1,510.5 (1.5) (0.7) (0.8)
(a) Determined by recording the balance of the available-for-sale financial assets fair value reserve relating to SGS in the income statement at the date of finalizing the sales transaction (€1,575.2 million), net of the negative difference of €41.2 million between the fair value of the investment determined at the same date on the basis of its market price (€2,044.9 million) and the sales price agreed between the parties (€2,003.7 million, net of incidental expenses on the sale of €0.1 million). (b) Reduction in the Deferred Price on the sale of Alpitour as a result of certain disputes that arose with the buyer. (c) Equal to the difference between the proceeds of €223.2 million (net of incidental expenses of €1.8 million incurred on the sale) and the carrying amount at June 30, 2011 of €60.9 million. (d) Of which -€103.8 million is for the fair value adjustment, -€50.6 million for the diluting effect on capital and +€7 million for other consolidation adjustments
Commercial Register No.64236277 Note legali | Credits